Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/18/2009CN100560074C External patch containing estrogen and/or progestogen
11/18/2009CN100560073C N4-acylcytosine nucleosides for treatment of viral infections
11/18/2009CN100560072C Hydrochloric acid olprinone injection and method for preparing the same
11/18/2009CN100560071C Antimicrobial compositions
11/18/2009CN100560070C Imidazol derivatives having affinity for alpha 2 receptors activity
11/18/2009CN100560069C Mitiglinide calcium formulation and its detection method
11/18/2009CN100560068C Levogyration sulpiride injection preparation method
11/18/2009CN100560067C Hydrochloric acid dronedarone medicinal compositions for oral use and method for preparing the same
11/18/2009CN100560066C Preparation method of a compound glutamine medicine composition
11/18/2009CN100560065C Asarone fatty emulsion and its preparing method
11/18/2009CN100560064C Method for preparing flupentixol and melitracen capsule
11/18/2009CN100560062C Clindamycin phosphate freeze-dried powder needle and preparation thereof
11/18/2009CN100560061C Lornoxicam freeze-dried injection and preparation method thereof
11/18/2009CN100560058C Fast-effective oral analgesic
11/18/2009CN100560056C Compound all-trans retinoic acid cream and its preparation method and application
11/18/2009CN100560050C Use of total cistanchis glycoside for inhibiting skin pigment deposition and whitening
11/17/2009US7619115 Ortho-substituted N'-benzylidene-(3-hydroxyphenyl)acethydrazides
11/17/2009US7619100 Physiologically active substances
11/17/2009US7619097 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus
11/17/2009US7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/17/2009US7619095 A 4-(2-(dipropylamine0ethyl)-2,3-dihydro-1H-indol-2-one and novel chemical intermediates; reducing 3-nitro-2-methylbenzoic acid using borohydride in presence of sulfonic or sulfuric acid; forming the corresponding benzylalcohol and corresponding phenylacetic acid; reacting with dipropylamine compound
11/17/2009US7619094 Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
11/17/2009US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009US7619091 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052)
11/17/2009US7619086 HIV integrase inhibitors
11/17/2009US7619083 Intermediates useful in preparing certain pyrrolotriazine compounds and process for making such intermediates
11/17/2009US7619066 IL-1ra variants
11/17/2009US7619058 Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same
11/17/2009US7619008 Xylitol for treatment of vaginal infections
11/17/2009US7619007 Provides pharmaceutical compositions that are administered so as to deliver to a subject, an amount of an NMDAr antagonist that is high enough to treat symptoms or damaging effects of an underlying disease while avoiding undesirable side effects, particularly CNS side effects
11/17/2009US7619006 Conjugates with organic acids; uses thereof in the treatment of psychotic and/or proliferative disorders and diseases and as chemosensitizing agents; the organic acids are selected to reduce side effects induced by the psychotropic drugs and/or to exert an anti-proliferative activity
11/17/2009US7619005 With particular enantiomers levo-amphetamine or levo-methamphetamine without adverse side effects
11/17/2009US7619004 Method of using colchicine for prophylactic treatment of gout flares in a human gout patient so as to reduce the occurrence of colchicine toxicity when patient is receiving concomitant administration of clarithromycin; dosage adjustment
11/17/2009US7619003 Via acid and basic catalysts; improved efficiency
11/17/2009US7619002 Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events
11/17/2009US7619001 Utilization of dialkylfumarates
11/17/2009US7619000 S-dimethylarsino-thiosuccinic acid S-dimethylarsino-2-thiobenzoic acid S-(dimethylarsino) glutathione as treatments for cancer
11/17/2009US7618999 Process of obtaining taxosteroids and precursors thereof
11/17/2009US7618998 For treatment of osteoporosis
11/17/2009US7618997 Such as 4-amino-5-(N-methylamino)-2',7'-difluoro-3',6'-dihydroxy-spiro[isobenzofuran-1 (3H),9'-[9H]xanthen]-3-one for use as agents for measurement of nitrogen monoxide
11/17/2009US7618996 Diaryl ether derivatives and uses thereof
11/17/2009US7618995 Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
11/17/2009US7618994 Such as (+/-)-[9-(4-chlorobenzyl)-6-fluoro-8-methanesulfonyl-2, 3,4,9-tetrahydro-1H-carbazol-1-yl]acetic acid; prostaglandin receptor antagonists; antihistamines; nasal decongestion, rhinitis
11/17/2009US7618993 Compounds
11/17/2009US7618991 Diaryloxazole carboxamide derivatives for treating a disease selected from appetite disorder, metabolic disorder, gastrointestinal disorder, inflammatory phenomena, immune system disease, psychotic disorder, alcohol dependency and nicotine dependency
11/17/2009US7618990 4-[2-(4,4-Dimethyl-2-thioxo-1,3-oxazolidin-3-yl)-1,3-thiazol-4-yl]benzonitrile; progesterone receptor (PR); contraception, treating or preventing fibroids, endometriosis, dysfunctional bleeding, uterine leiomyomata, polycystic ovary syndrome, or hormone-dependent carcinomas, hormone replacement therapy
11/17/2009US7618989 Tricyclic oxazolidone derivatives useful as PR modulators
11/17/2009US7618988 Use of substituted aminomethyl chromans
11/17/2009US7618987 Acylated piperidine derivatives as melanocortin 4-receptor agonists
11/17/2009US7618986 Method of treating latent tuberculosis
11/17/2009US7618985 Isoquinoline derivatives
11/17/2009US7618984 Sulfonamide compound
11/17/2009US7618983 Bicyclic triazole α4 integrin inhibitors
11/17/2009US7618981 Imidazopyridinyl-benzamide anti-cancer agents
11/17/2009US7618980 Pyrrolo(oxo)quinolines as 5HT ligands
11/17/2009US7618979 Prostaglandin receptor antagonists; allergic rhinitis, nasal congestion and asthma; [5-[(4-chlorophenyl)thio]-4-(methylsulfonyl)-6,7,8,9-tetrahydropyrido[3,2-b]indolizin-6-yl]acetic acid
11/17/2009US7618978 Amides as BACE inhibitors
11/17/2009US7618977 Method of treating dermatitis comprising administering a chymase inhibitor
11/17/2009US7618976 Methods for the production of sildenafil base and citrate salt
11/17/2009US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009US7618974 Gyrase inhibitors and uses thereof
11/17/2009US7618973 Alzheimer's disease; gamma-aminobutyric acid inhibitors; 5-(5-methyl-3-phenyl-isoxazol-4-ylmethoxy)-pyrazine-2-carboxylic acid methyl ester
11/17/2009US7618972 Sexual disorders; premature labor; eating disorders; dymenorrhoea; congestive heart failure
11/17/2009US7618971 Mitotic kinesin inhibitors
11/17/2009US7618970 To treat inflammatory diseases, immune diseases and cancer; N-[(1R,3S)-3-Isopropyl-3-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}carbonyl)cyclopentyl]-3-methoxytetrahydro-2H-pyran-4-amine; side effect reduction; improved long term safety profile; oral administration; half life
11/17/2009US7618969 Compounds which potentiate glutamate receptor and uses thereof in medicine
11/17/2009US7618968 Aryl triazines as LPAAT-β inhibitors and uses thereof
11/17/2009US7618967 Indane compounds
11/17/2009US7618965 (Arylamidoanilino)nitroethylene compounds
11/17/2009US7618964 Benzamide derivatives, their manufacture and use as pharmaceutical agents
11/17/2009US7618963 Bicyclic heteroaromatic compounds
11/17/2009US7618962 Pyrazolyl substituted xanthines
11/17/2009US7618961 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia
11/17/2009US7618960 Morpholine type cinnamide compound
11/17/2009US7618959 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
11/17/2009US7618958 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
11/17/2009US7618957 1-N-(Benzyloxycarbonyl)-1H,1H,2H,2H,4H,4H,5H,5H-3-aza-perfluorotridecylamine; used in NMR and x-ray diagnosis, radiodiagnosis, and radiotherapy, as well as in MRT lymphography and in blood-pool imaging
11/17/2009US7618956 Reduction of hair growth
11/17/2009US7618955 Association of an antithrombotic and aspirin
11/17/2009US7618954 Inositol pyrophosphates, and methods of use thereof
11/17/2009US7618953 Amorphous forms of risedronate monosodium
11/17/2009US7618952 Fungicides; pest control; 1-Dimethyl-3-(2'-nitro)phenyl-silacyclohexene-2; Trans-1-(2'trifluoromethylsulfonyloxy-phenyl)-2-trimethylsilyl-cyclopropane
11/17/2009US7618951 Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes
11/17/2009US7618950 Method for treatment and prevention of herpes zoster by topical application
11/17/2009US7618949 Drug-eluting stents coated with P2Y12 receptor antagonist compound
11/17/2009US7618948 Brain delivery of small interfering RNA or vectors containing the DNA encoding for small interfering RNA; beneficial effects on improving memory and/or cognitive function in a subject.
11/17/2009US7618947 Antisense compounds, especially nucleic acid and nucleic acid-like oligomers, which are targeted to a nucleic acid encoding HIF1-beta, and which modulate the expression of HIF1-beta; for inhibiting tumor growth, ocular neovascularization
11/17/2009US7618946 Analgesic compounds, extracts containing same and methods of preparation
11/17/2009US7618943 Fusion polypeptides, and use thereof in antivascular tumor therapy
11/17/2009US7618940 Identidying modulators of hypoxia inducible factor protein for use in controlling fat metabolism and prevention and treating of obesity, diabetes and atherosclerosis
11/17/2009US7618785 Diagnostic and therapeutic methods based on the L1 adhesion molecule for ovarian and endometrial tumors
11/17/2009US7618658 applying a Sasa plant extract on skin for treating Propionibacterium infections
11/17/2009US7618656 treatment of hyperphosphatemia, high level of phosphates in blood; oral administration; x-ray powder diffraction (XRPD) analysis to determine the level of the degradation products (LaOHCO3) in the rare earth compound itself (La2(CO3)3.xH2O)
11/17/2009US7618652 Glycosaminoglycan anticoagulants derived from fish
11/17/2009US7618651 gel comprising glycerol formal solvent, hydroxypropyl methylcellulose and a dissolved antibacterial agent Tobramycin, antifungal agent Terbinafine , and a steroid Betamethasone; controlled- or sustained-release; treating microbial infection of the skin, ear, or eye, especially for veterinary medicine
11/17/2009US7618650 Combination of a hypnotic agent and substituted bis aryl and heteroaryl compound and therapeutic application thereof
11/17/2009US7618649 For therapy of nasal and non-nasal symptoms of perennial and seasonal allergic rhinitis
11/17/2009US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease
11/17/2009US7618636 Sequences from the bacterium Neisseria meningitidis.
11/17/2009US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses
1 ... 2500 2501 2502 2503 2504 2505 2506 2507 2508 2509 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 ... 7860